These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33523591)

  • 1. Pediatric high-grade glioma: moving toward subtype-specific multimodal therapy.
    Chatwin HV; Cruz Cruz J; Green AL
    FEBS J; 2021 Nov; 288(21):6127-6141. PubMed ID: 33523591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
    Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
    J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemispherical Pediatric High-Grade Glioma: Molecular Basis and Therapeutic Opportunities.
    Haase S; Nuñez FM; Gauss JC; Thompson S; Brumley E; Lowenstein P; Castro MG
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric Hemispheric High-Grade Gliomas and H3.3-G34 Mutation: A Review of the Literature on Biological Features and New Therapeutic Strategies.
    Bonada M; Pittarello M; De Fazio E; Gans A; Alimonti P; Slika H; Legnani F; Di Meco F; Tyler B
    Genes (Basel); 2024 Aug; 15(8):. PubMed ID: 39202398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutting Edge Therapeutic Insights Derived from Molecular Biology of Pediatric High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG).
    Bailey CP; Figueroa M; Mohiuddin S; Zaky W; Chandra J
    Bioengineering (Basel); 2018 Oct; 5(4):. PubMed ID: 30340362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Genetics and Targeted Therapies for Paediatric High-grade Glioma.
    Rallis KS; George AM; Wozniak AM; Bigogno CM; Chow B; Hanrahan JG; Sideris M
    Cancer Genomics Proteomics; 2022; 19(4):390-414. PubMed ID: 35732328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulating autophagy as a therapeutic strategy for the treatment of paediatric high-grade glioma.
    Howarth A; Madureira PA; Lockwood G; Storer LCD; Grundy R; Rahman R; Pilkington GJ; Hill R
    Brain Pathol; 2019 Nov; 29(6):707-725. PubMed ID: 31012506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children's Hospital experience.
    Crotty EE; Leary SES; Geyer JR; Olson JM; Millard NE; Sato AA; Ermoian RP; Cole BL; Lockwood CM; Paulson VA; Browd SR; Ellenbogen RG; Hauptman JS; Lee A; Ojemann JG; Vitanza NA
    J Neurooncol; 2020 Jul; 148(3):607-617. PubMed ID: 32556862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study.
    Perwein T; Giese B; Nussbaumer G; von Bueren AO; van Buiren M; Benesch M; Kramm CM
    J Neurooncol; 2023 Feb; 161(3):525-538. PubMed ID: 36720762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenging the indiscriminate use of temozolomide in pediatric high-grade gliomas: A review of past, current, and emerging therapies.
    Guerra-García P; Marshall LV; Cockle JV; Ramachandran PV; Saran FH; Jones C; Carceller F
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28011. PubMed ID: 31617673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiosensitization in Pediatric High-Grade Glioma: Targets, Resistance and Developments.
    Metselaar DS; du Chatinier A; Stuiver I; Kaspers GJL; Hulleman E
    Front Oncol; 2021; 11():662209. PubMed ID: 33869066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genetic signatures of pediatric high-grade glioma: no longer a one-act play.
    Diaz AK; Baker SJ
    Semin Radiat Oncol; 2014 Oct; 24(4):240-7. PubMed ID: 25219808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Landscape of Pediatric High-Grade Gliomas: The Virtues and Pitfalls of Pre-Clinical Models.
    Furst LM; Roussel EM; Leung RF; George AM; Best SA; Whittle JR; Firestein R; Faux MC; Eisenstat DD
    Biology (Basel); 2024 Jun; 13(6):. PubMed ID: 38927304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric hemispheric high-grade glioma: targeting the future.
    Coleman C; Stoller S; Grotzer M; Stucklin AG; Nazarian J; Mueller S
    Cancer Metastasis Rev; 2020 Mar; 39(1):245-260. PubMed ID: 31989507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celastrol-induced degradation of FANCD2 sensitizes pediatric high-grade gliomas to the DNA-crosslinking agent carboplatin.
    Metselaar DS; Meel MH; Benedict B; Waranecki P; Koster J; Kaspers GJL; Hulleman E
    EBioMedicine; 2019 Dec; 50():81-92. PubMed ID: 31735550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric Gliomas: Current Concepts on Diagnosis, Biology, and Clinical Management.
    Sturm D; Pfister SM; Jones DTW
    J Clin Oncol; 2017 Jul; 35(21):2370-2377. PubMed ID: 28640698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual HDAC and PI3K Inhibition Abrogates NFκB- and FOXM1-Mediated DNA Damage Response to Radiosensitize Pediatric High-Grade Gliomas.
    Pal S; Kozono D; Yang X; Fendler W; Fitts W; Ni J; Alberta JA; Zhao J; Liu KX; Bian J; Truffaux N; Weiss WA; Resnick AC; Bandopadhayay P; Ligon KL; DuBois SG; Mueller S; Chowdhury D; Haas-Kogan DA
    Cancer Res; 2018 Jul; 78(14):4007-4021. PubMed ID: 29760046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considerations when treating high-grade pediatric glioma patients with immunotherapy.
    Crotty E; Downey K; Ferrerosa L; Flores C; Hegde B; Raskin S; Hwang E; Vitanza N; Okada H
    Expert Rev Neurother; 2021 Feb; 21(2):205-219. PubMed ID: 33225764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic inhibition of lysine-specific demethylase 1 as a therapeutic and immune-sensitization strategy in pediatric high-grade glioma.
    Bailey CP; Figueroa M; Gangadharan A; Yang Y; Romero MM; Kennis BA; Yadavilli S; Henry V; Collier T; Monje M; Lee DA; Wang L; Nazarian J; Gopalakrishnan V; Zaky W; Becher OJ; Chandra J
    Neuro Oncol; 2020 Sep; 22(9):1302-1314. PubMed ID: 32166329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in pediatric gliomas: from molecular characterization to personalized treatments.
    Sathyakumar S; Martinez M; Perreault S; Legault G; Bouffet E; Jabado N; Larouche V; Renzi S
    Eur J Pediatr; 2024 Jun; 183(6):2549-2562. PubMed ID: 38558313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.